Literature DB >> 23299924

Pleural mesothelial cells promote expansion of IL-17-producing CD8+ T cells in tuberculous pleural effusion.

X Li1, Q Zhou, W B Yang, X Z Xiong, R H Du, J C Zhang.   

Abstract

IL-17-producing CD8(+) T lymphocytes (Tc17 cells) have recently been detected in many cancers and autoimmune diseases. However, the possible implication of Tc17 cells in tuberculous pleural effusion remains unclarified. In this study, distribution and phenotypic features of Tc17 cells in both tuberculous pleural effusion (TPE) and peripheral blood from patients with tuberculosis were determined. The effects of proinflammatory cytokines and local accessory cells (pleural mesothelial cells) on Tc17 cell expansion were also explored. We found that TPE contained more Tc17 cells than the blood. Compared with IFN-γ-producing CD8(+) T cells, Tc17 cells displayed higher expression of chemokine receptors (CCRs) and lower expression of cytotoxic molecules. In particularly, Tc17 cells in TPE exhibited high expression levels of CCR6, which could migrate in response to CCL20. Furthermore, IL-1β, IL-6, IL-23, or their various combinations could promote Tc17 cell expansion from CD8(+) T cells, whereas the proliferative response of Tc17 cells to above cytokines was lower than that of Th17 cells. Pleural mesothelial cells (PMCs) were able to stimulate Tc17 cell expansion via cell contact in an IL-1β/IL-6/IL-23 independent fashion. Thus this study demonstrates that Tc17 cells marks a subset of non-cytotoxic, CCR6(+) CD8(+) T lymphocytes with low proliferative capacity. The overrepresentation of Tc17 cells in TPE may be due to Tc17 cell expansion stimulated by pleural proinflammatory cytokines and to recruitment of Tc17 cells from peripheral blood. Additionally, PMCs may promote the production of IL-17 by CD8(+) T cells at sites of TPE via cell-cell interactions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23299924     DOI: 10.1007/s10875-012-9860-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  46 in total

1.  Functional expression of chemokine receptor CCR6 on human effector memory CD8+ T cells.

Authors:  Takaaki Kondo; Hiroshi Takata; Masafumi Takiguchi
Journal:  Eur J Immunol       Date:  2007-01       Impact factor: 5.532

Review 2.  How can immunology contribute to the control of tuberculosis?

Authors:  S H Kaufmann
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

Review 3.  IL-17 in protective immunity to intracellular pathogens.

Authors:  Shabaana A Khader; Radha Gopal
Journal:  Virulence       Date:  2010 Sep-Oct       Impact factor: 5.882

4.  Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients.

Authors:  Dong-Ming Kuang; Chen Peng; Qiyi Zhao; Yan Wu; Ling-Yan Zhu; Jianen Wang; Xiao-Yu Yin; Lian Li; Limin Zheng
Journal:  J Immunol       Date:  2010-06-25       Impact factor: 5.422

5.  Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions.

Authors:  C C Hua; L C Chang; Y C Chen; S C Chang
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

6.  Differentiation and recruitment of IL-22-producing helper T cells stimulated by pleural mesothelial cells in tuberculous pleurisy.

Authors:  Zhi-Jian Ye; Qiong Zhou; Ming-Li Yuan; Rong-Hui Du; Wei-Bing Yang; Xian-Zhi Xiong; Bo Huang; Huan-Zhong Shi
Journal:  Am J Respir Crit Care Med       Date:  2011-12-28       Impact factor: 21.405

7.  IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection.

Authors:  Euan Lockhart; Angela M Green; JoAnne L Flynn
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

8.  Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice.

Authors:  N V Serbina; J L Flynn
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 9.  IL-23 and IL-17 in tuberculosis.

Authors:  Shabaana A Khader; Andrea M Cooper
Journal:  Cytokine       Date:  2008-01-22       Impact factor: 3.861

10.  The ex vivo production of IL-6 and IL-21 by CD4+ T cells is directly associated with neurological disability in neuromyelitis optica patients.

Authors:  Ulisses C Linhares; Patrícia B Schiavoni; Priscila O Barros; Taissa M Kasahara; Bruna Teixeira; Thais B Ferreira; Regina Alvarenga; Joana Hygino; Morgana M M Vieira; Vera Carolina B Bittencourt; Regis M Andrade; Arnaldo F Andrade; Cleonice A M Bento
Journal:  J Clin Immunol       Date:  2012-09-05       Impact factor: 8.317

View more
  6 in total

1.  Specific immunotherapy generates CD8(+) CD196(+) T cells to suppress lung cancer growth in mice.

Authors:  Jian Zhang; Jing Liu; Huiguo Chen; Weibin Wu; Xiaojun Li; Yonghui Wu; Zhigang Wang; Kai Zhang; Yun Li; Yimin Weng; Hongying Liao; Lijia Gu
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

2.  Cell origins and significance of IL-17 in malignant pleural effusion.

Authors:  Y Gong; S X Chen; B A Gao; R C Yao; L Guan
Journal:  Clin Transl Oncol       Date:  2014-01-08       Impact factor: 3.405

Review 3.  IL-17+ CD8+ T cells: Differentiation, phenotype and role in inflammatory disease.

Authors:  Ushani Srenathan; Kathryn Steel; Leonie S Taams
Journal:  Immunol Lett       Date:  2016-05-09       Impact factor: 3.685

4.  GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis.

Authors:  Thomas H King; Crystal A Shanley; Zhimin Guo; Donald Bellgrau; Timothy Rodell; Synthia Furney; Marcela Henao-Tamayo; Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

5.  Mycobacterium smegmatis Vaccine Vector Elicits CD4+ Th17 and CD8+ Tc17 T Cells With Therapeutic Potential to Infections With Mycobacterium avium.

Authors:  Nisha Kannan; Markus Haug; Magnus Steigedal; Trude Helen Flo
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

6.  Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression.

Authors:  Bina Menon; Nicola J Gullick; Gina J Walter; Megha Rajasekhar; Toby Garrood; Hayley G Evans; Leonie S Taams; Bruce W Kirkham
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.